07:00 , Mar 12, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: E. coli disulfide bond formation protein B (DsbB)

Infectious disease INDICATION: Gram-negative bacterial infection In vitro studies suggest DsbB inhibitors could help treat Gram-negative bacterial infections. DsbB enables disulfide bond formation that stabilizes bacterial virulence factors. Library screening in an Escherichia coli-based disulfide...